| Title: | The role of antibody-drug conjugates in the treatment of lung cancer |
|---|
| Authors: | ID Zlatanova, Tanya (Author)
ID Changalova, Aynura (Author)
ID Janžič, Urška, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Author) |
|---|
| Files: |  URL - Source URL, visit https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1757564/full
 PDF - Presentation file, download (1,73 MB)
MD5: 89294717696C65E25AAE4B6C1018ED62
|
|---|
| Language: | English |
|---|
| Typology: | 1.01 - Original Scientific Article |
|---|
| Organization: |  UKPBAG - University Clinic of Respiratory and Allergic Diseases Golnik
|
|---|
| Abstract: | Over the last decades, lung cancer treatment has improved immensely, mainly due to the incorporation of new targeted treatments and immunotherapy. A relatively new and potentially highly effective class of drugs, antibody-drug conjugates (ADCs), has been introduced to the clinical setting and is currently under intense investigation, alone and in combination with other molecules. This study aims to summarize the latest data on ADCs for lung cancer treatment and to analyze their potential, toxicity profile, and challenges. |
|---|
| Keywords: | ADC, antibody-drug conjugate, non-small cell lung cancer, small-cell lung cancer, targeted therapy, immunotherapy |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Submitted for review: | 30.11.2025 |
|---|
| Article acceptance date: | 22.01.2026 |
|---|
| Publication date: | 05.02.2026 |
|---|
| Publisher: | Frontiers Editorial Office, 2011- |
|---|
| Year of publishing: | 2026 |
|---|
| Number of pages: | 18 str. |
|---|
| Numbering: | Vol. 16, article no. ǂ1757564 |
|---|
| Source: | Frontiers in oncology |
|---|
| PID: | 20.500.12556/DiRROS-27400  |
|---|
| UDC: | 616.24-006:615.277 |
|---|
| ISSN on article: | 2234-943X |
|---|
| DOI: | 10.3389/fonc.2026.1757564 |
|---|
| COBISS.SI-ID: | 267418115 |
|---|
| Copyright: | © 2026 Zlatanova, Changalova and Janzic. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
|---|
| Note: | Nasl. z nasl. zaslona;
Vse avtorice so k temu delu prispevale enakovredno;
Soavtorica iz Slovenije: Urška Janžič;
Opis vira z dne 5. 2. 2026;
|
|---|
| Publication date in DiRROS: | 05.02.2026 |
|---|
| Views: | 557 |
|---|
| Downloads: | 186 |
|---|
| Metadata: |    |
|---|
|
:
|
Copy citation |
|---|
| | | | Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
